Optimizing Clinical Trials Using Adaptive Design: Early Alignment for Success, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speaker will address key considerations for utilizing an adaptive design and evaluate how risk profiles can affect adaptive design. The webinar will also explore how the FDA’s Complex Innovative Design program is changing the way adaptive designs are viewed.

Xtalks Life Science Webinars

This webinar will provide a deep dive into what questions drug developers can ask themselves to determine whether their development plan is a candidate for incorporating some aspects of an adaptive design and if the plan may be better suited to an early or late phase adaptive design.

Join industry expert Christopher Tait, PhD, Senior Biostatistician, Synteract in a live session on Thursday, July 2, 2020 at 11am EDT (4pm BST/UK).

Adaptive designs are a wide umbrella for any design which changes during a trial, but in a pre-specified manner. They may allow for earlier go/no-go decisions and the ability to potentially answer more questions than traditional drug development. For example, testing additional small population subgroups (or tumor types) to be included in a basket trial could result in the approval in any or all groups when those smaller populations may have been excluded in a standard trial. Adaptive designs could include the use of a historical control, borrowing across treatment arms and/or tumor types, adjusting the sample size during the trial, dropping unfavorable arms and/or stopping early due to effectiveness.

Adaptive designs used to have a stigma with some designs, even being considered not “well-understood.” However, regulatory agencies and drug developers are starting to see what fruits these designs may bear, as examples of success include master protocols/platform/umbrella trials, the PREVAIL II Ebola trial and other published studies. These results of interaction with the FDA through the Complex Innovative Design program have become available to the public.

This webinar will provide a deep dive into what questions drug developers can ask themselves to determine whether their development plan is a candidate for incorporating some aspects of an adaptive design and if the plan may be better suited to an early or late phase adaptive design. It will offer an expanded understanding of exactly what it means to run an adaptive trial.

For more information or to register for this event, visit Optimizing Clinical Trials Using Adaptive Design: Early Alignment for Success.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website